anvisa

Health

Anvisa investigates 13 eye disease cases linked to GLP-1 drugs

Brazil's health regulator Anvisa is investigating 13 cases of a rare eye condition causing vision loss in patients using GLP-1 weight-loss and diabetes drugs.